| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 06/14/2007 | US20070135386 Novel Compounds and Compositions as Cathepsin Inhibitors |
| 06/14/2007 | US20070134802 Ionization modifier for mass spectrometry |
| 06/14/2007 | US20070134729 Novel antibacterial agents |
| 06/14/2007 | US20070131616 Optically active maleimide derivatives, optically active polymaleimide derivatives, process for their production, separating media comprising the optically active polymaleimide derivatives and method of separating optically active compounds using them |
| 06/14/2007 | CA2632453A1 3-carboxy- 2-oxo-1 -pyrrolidine derivatives and their uses |
| 06/13/2007 | EP1795529A2 Process for producing N-(Hetero)Aryl-substituted nitrogen-containing heteroaryl compound |
| 06/13/2007 | EP1794129A2 Synthesis by chiral diamine-mediated asymmetric alkylation |
| 06/13/2007 | EP1794120A2 Peptidase inhibitors |
| 06/13/2007 | EP1437353B1 Alkyl ether derivatives or salts thereof |
| 06/13/2007 | EP1214292B1 Tyrosine derivatives |
| 06/13/2007 | CN1980936A 2,4,6-phenylsubstituted cyclic ketoenoles. |
| 06/13/2007 | CN1980904A CETP inhibitors |
| 06/13/2007 | CN1980892A Dpp-IV inhibitors |
| 06/13/2007 | CN1980890A Process for the preparation of atorvastatin |
| 06/13/2007 | CN1980889A Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 06/13/2007 | CN1978444A Photochromic thiophene pyrrole mixed linkage type dithienylethene compounds, and their synthesizing and use |
| 06/13/2007 | CN1978440A Process for producing N-(hetero)aryl-substituted nitrogen-containing heteroaryl compound |
| 06/13/2007 | CN1321129C Inhibitors of caspases |
| 06/13/2007 | CN1321101C New retinoids for the treatment of emphysema |
| 06/12/2007 | US7230144 Methods of making intermediates from polyhydroxyalkanoates |
| 06/12/2007 | US7230120 Amorphous HMG-CoA reductase inhibitors of desired particle size |
| 06/12/2007 | US7230119 Especially 4-(hydroxymethyl)pyrrolidin-3-ol, using camphor sultam as an intermediate; final steps include reducing N-[[3S,4R)-4-Benzyloxy-1-(benzyl)pyrrolidin-3-yl]carbonyl]-(2'S)-bornane-10,2-sultam and deprotecting the (3R,4R)-(1-Benzyl-4-benzyloxypyrrolidin-3-yl)methanol formed through hydrogenation |
| 06/12/2007 | US7229991 Substituted 5-aminomethyl-1H-pyrrole-2-carboxamides |
| 06/12/2007 | US7229988 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
| 06/12/2007 | US7229987 Oxazoles with one or more tertiary amine groups and phenyl groups, e.g., 1-{4-[2-(Benzofuran-2-ylmethoxymethyl)-oxazol-5-yl]-phenyl}-3-(2-dimethylamino-ethyl)-urea and -(3-{4-[2-(2-Phenoxy-ethylsulfanylmethyl)-oxazol-5-yl]-phenoxy}-propyl)-azepine; treating obesity and related diseases, e.g., diabetes |
| 06/12/2007 | US7229629 Oxidation resistance |
| 06/12/2007 | CA2354023C Phenylglycine derivatives |
| 06/07/2007 | WO2007064749A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | WO2007064732A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | WO2007064306A1 Method of preparation of maleimides by thermal cyclization of maleamic acids in th presence of a catalyst |
| 06/07/2007 | WO2007063925A1 2-aminobenzamide derivative |
| 06/07/2007 | WO2007063839A1 Cyclohexane derivative |
| 06/07/2007 | WO2007063551A1 POLYMORPHS OF [R-(R*, R*)]-2-(4-FLUOROPHENYL)-β,δ-DIHYDROXY-5-(l-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-lH-PYRROLE-l-HEPTANOIC ACID MAGNESIUM SALT (2: 1) |
| 06/07/2007 | WO2007063009A1 Serotonin transporter (sert) inhibitors |
| 06/07/2007 | WO2007045420A3 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
| 06/07/2007 | WO2007043677A9 Hydrazide compound and pesticidal use of the same |
| 06/07/2007 | WO2006103696B1 Process for preparing levetiracetam and racemization of (r)- and (s)-2-amino butynamide and the corresponding acid derivatives |
| 06/07/2007 | US20070129420 New pyrrolidinium derivatives |
| 06/07/2007 | US20070129419 Serotonin transporter (SERT) inhibitors for the treatment of depression and anxiety |
| 06/07/2007 | US20070129397 Ester derivatives |
| 06/07/2007 | US20070129381 Pharmaceutically active pyrrolidine ester derivatives |
| 06/07/2007 | US20070129346 Melanocortin receptor agonists |
| 06/07/2007 | US20070129252 2-Halo-6-alkylphenyl-substituted spirocyclic tetramic acid derivatives |
| 06/07/2007 | CA2632922A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | CA2632921A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | CA2631741A1 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 06/07/2007 | CA2631549A1 Polymorphs of [r-(r*, r*)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-lh-pyrrole-l-heptanoic acid magnesium salt (2: 1) |
| 06/07/2007 | CA2631221A1 Serotonin transporter (sert) inhibitors |
| 06/07/2007 | CA2629964A1 2-aminobenzamide derivative |
| 06/06/2007 | EP1792901A1 N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides |
| 06/06/2007 | EP1792624A1 Modified amino acids and compositions comprising them for delivering active agents |
| 06/06/2007 | EP1791825A1 Benzoyl-substituted serine amides |
| 06/06/2007 | EP1791816A1 Iodine-phenyl-substituted cyclic cetoenols |
| 06/06/2007 | EP1791815A2 Pyrrolidine derivatives acting as ccr3-receptor antagonists |
| 06/06/2007 | EP1791810A1 4-aminomethyl benzamidine derivatives and their use as factor viia inhibitors |
| 06/06/2007 | EP1791809A1 Substituted aniline derivatives |
| 06/06/2007 | EP1791536A1 1-[(3r)-amino-4-(2-fluoro-phenyl)-butyl]-pyrrolidine-(2r)-carboxylic acid-benzyl amine derivatives and related compounds as dipeptidyl-peptidase iv (dpp-iv) inhibitors for the treatment of type 2 diabetes mellitus |
| 06/06/2007 | EP1680400B1 Derivatives of n-[ phenyl(pyrrolidine-2-yl)methyl]benzamide and n-[ (azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics |
| 06/06/2007 | EP1483578A4 Artificial receptors, building blocks, and methods |
| 06/06/2007 | EP1387824B1 Method for purifying a raw melt of at least one monomer by crystallization |
| 06/06/2007 | DE102005058166A1 Matrixkontrolliertes transdermales System mit Amin-Salzen der ACE-Hemmer-Dicarbonsäuren Controlled matrix transdermal system with amine salts of the ACE inhibitor dicarboxylic acids |
| 06/06/2007 | CN1976920A N-type calcium channel blockers |
| 06/06/2007 | CN1974596A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 06/06/2007 | CN1974545A Long chain fatty acyl amide compound and its application |
| 06/06/2007 | CN1320378C Filters for electronic displays |
| 06/06/2007 | CN1319929C Aryl phenyl substituted cyclic ketoenols |
| 06/05/2007 | US7227029 Reacting butyrolactone with methylamine; heating, pressurization |
| 06/05/2007 | US7227028 Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof |
| 06/05/2007 | US7226950 Sodium channel modulators |
| 06/05/2007 | US7226938 Heterocyclic compounds |
| 06/05/2007 | US7226937 Methods for modulating phototoxicity |
| 06/05/2007 | US7226929 drugs such as 6 -Chloro-N-{(3S)-1-[(1S)-1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide, used as antithrombotic agents |
| 06/05/2007 | US7226917 Derivatives of N-[phenyl(pyrrolidine-2-yl)methyl]benzamide and N-[(azepan-2-yl)phenylmethyl]benzamide, preparation, and use in treatment of schizophrenia |
| 06/05/2007 | CA2262847C Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a2 |
| 05/31/2007 | WO2007061153A1 Compounds inducing differentiation of myoblasts or muscle fibers into neuron cells, pharmaceutical composition including said compounds, a method for inducing neuron differentiation and a screening method for identifying additional compounds useful for inducing neuron differentiation |
| 05/31/2007 | WO2007060526A1 Substituted azacycloalkanes useful for treating cns conditions |
| 05/31/2007 | WO2007060166A1 New n-phenethylcarboxamide derivatives |
| 05/31/2007 | WO2007060164A1 N-(1-alkyl-2-phenylethyl)-carboxamide derivatives and use thereof as fungicides |
| 05/31/2007 | WO2007037518A9 Mutilin derivative and pharmaceutical composition containing the same |
| 05/31/2007 | WO2007025763A3 Highly cross-linked reagents for modifying biopharmaceuticals, production and use thereof |
| 05/31/2007 | WO2007019255A3 Salts of vildagliptin |
| 05/31/2007 | WO2007008657A3 Hepatitis c virus inhibitors |
| 05/31/2007 | US20070123709 Beta-amino acids |
| 05/31/2007 | CA2630558A1 Catalyzed process of making c-5-substituted heterocyclic inhibitors of 11.beta.-hydroxy steroid dehydrogenase type 1 |
| 05/31/2007 | CA2630459A1 Substituted azacycloalkanes useful for treating cns conditions |
| 05/31/2007 | CA2630234A1 Thrombopoietin activity modulating compounds and methods |
| 05/30/2007 | EP1789377A1 Alternative synthesis of renin inhibitors and intermediates thereof |
| 05/30/2007 | EP1263723B1 Ningalin b analogs employable for reversing multidrug resistance |
| 05/30/2007 | EP1003730B1 2-benzoyl-cyclohexane-1,3-diones |
| 05/30/2007 | EP0914605B1 Molecular model for vla-4 inhibitors |
| 05/30/2007 | CN1972910A 内酰胺速激肽受体拮抗剂 Lactam tachykinin receptor antagonists |
| 05/30/2007 | CN1972904A Preparation of pregabalin and related compounds |
| 05/30/2007 | CN1970553A 5-amido-2-[(4-methoxyl-3-methyl-2-pyridinyl)-methylthio]-1-hydro-benzimidazole and its derivative synthesis method |
| 05/30/2007 | CN1970523A Alpha,beta-unsaturated ketone or arone environment-friendly synthesis method |
| 05/30/2007 | CN1318402C Pyrrolidine-2-carboxylic acid hydrozide derivatives for use as metalloprotease inhibitors |
| 05/29/2007 | USRE39667 3,3-Diphenylpropylamines, their use and preparation |
| 05/29/2007 | US7223873 Process for preparing amines |
| 05/29/2007 | US7223870 Coupling with ligand such as ethylenediamine, diaminocyclohexane |
| 05/29/2007 | US7223796 Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use |
| 05/29/2007 | US7223793 Excellent effects of reducing blood lipid level, inhibiting cholesterol metabolism-related enzymes |